TYRA (Tyra Biosciences Inc) Margin bathi reged

Lambang korporat lan logo Tyra Biosciences Inc (TYRA)

Tyra Biosciences, Inc. (TYRA) is developing unique molecules to combat cancer resistance, driving an increase in share prices. Gross margin profitability confirms this trend, where the value of 0.00 reflects this status. The business relies on the success of FGFR clinical trials, while the targeted therapy sector demonstrates high resilience to economic cycles.

TYRA - Tingkat bathi miturut bathi reged tyra.bio ing rentang 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar Tyra Biosciences, Inc. (TYRA)

- rega saham lan prakiraan rega para ahli:
- indikator valuasi pasar bisnis:
Pambiji fundamental:TYRA Tyra Biosciences Inc
Barang unggulan Tyra Corp

For the research startup Tyra Biosciences (TYRA), whose costs are limited to laboratory expenses and reagent disposal, the gross margin reflects the efficiency of managing direct development costs. This indicator measures the portion of revenue remaining after deducting the cost of goods sold, allowing investors to assess the product's internal profitability by analyzing the gross margin chart for the business model's resilience to operational risks.